Industry association says Sweden ought to capitalize more on life science innovation

Sweden must become better at leveraging its life science innovation and research to halt foreign investors from taking advantage of the value created in the country, says IML, a Swedish life science organization.
Photo: Jens Dresling/Ritzau Scanpix
Photo: Jens Dresling/Ritzau Scanpix

While Sweden’s life science industry is a good innovator, producing a huge amount of research, it needs to improve when it comes to turning knowledge into action, says Johan Järte, managing director of Swedish life science association IML, as reported by national media Biostock.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading